Latest Breaking News On - Department of medicine center - Page 1 : comparemela.com

Research Reveals ERMA s Crucial Role in Cardiac Function

Research Reveals ERMA s Crucial Role in Cardiac Function
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesCity ofUnited kingdomNeelanjan vishnuAmy leMelanie narkunanLeroyc josephM imran aslamKarthik ramachandranPeterb stathopulosAbithak madeshMadesh muniswamyMridulak venkateswaranWenli yangManigandan venkatesan

Study discovers how a magnesium cellular transport pump plays a vital role in cardiac function

Study discovers how a magnesium cellular transport pump plays a vital role in cardiac function
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomMadesh muniswamyNeelanjan vishnuNational human genome research instituteUt health san antonioTeresa lozano long school of medicineUniversity of pennsylvaniaDivision of cardiologyColumbia universityNational institutes of healthDepartment of medicine centerMolecular cellTexas health science centerSan antonio

Children Treated With Remestemcel-L Show Long-Term Survival

Key Points: Long-term survival evident through 4 years in children treated with remestemcel-L in Phase 3 trial MSB-GVHD001Overall survival at 2 years.

United statesJoanne kurtzbergSilviu itescuSteve dabkowskiPatricia steinertPaul hughesMarrow transplant researchInternational bloodAustralian securities exchangeMarrow transplantation groupDuke university medical centerMesoblast limited nasdaqCorporate communications investorsDrug administrationNational marrow donor programInternational blood marrow

Children Treated With Remestemcel-L Show Long-Term Survival Through Four Years in Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

23.11.2022 - Key Points: Long-term survival evident through 4 years in children treated with remestemcel-L in Phase 3 trial MSB-GVHD001Overall survival at 2 years was 51% in remestemcel-L treated children and 25-38% in recently published studies of children . Seite 1

United statesJoanne kurtzbergPatricia steinertDuke university medical centerMesoblast limited nasdaqMarrow transplant researchDrug administrationInternational bloodInternational blood marrowDepartment of medicine centerKey pointsBiologics license applicationUnited states foodJerome harrisDistinguished professorExecutive scientific director